InvestorsHub on MSN
Roche receives FDA clearance for cobas BV/CV assay, expanding women’s health diagnostics
The new molecular test broadens Roche’s sexual-health diagnostics portfolio by enabling simultaneous detection of bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results